Search

everythinglearnresearchcommunity

for

Search:↓

Lacking cyclin D3 reduces skin cancer growth without affecting normal skin cell growth.

Milia may come from the outer part of the hair follicle.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Taking selenium supplements during chemotherapy may help reduce side effects and improve health markers in ovarian cancer patients.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Adverse events from vismodegib can be managed effectively to ensure optimal treatment.

Suppressing certain hormones might help prevent prostate cancer.

Orlistat might block the body's ability to absorb thyroid medication.

Hippocampus sparing whole brain radiation therapy prevents hair loss and preserves cognitive function.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Finasteride does not prevent bladder cancer.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Some cancer treatments can cause abnormal fine hair growth.

Scalp hypothermia can prevent chemotherapy-induced hair loss but is not suitable for all patients, and more research is needed to improve prevention methods.

Finasteride significantly reduces PSA levels in men, and doctors should adjust PSA readings for those taking the drug.

A man's bald spot grew hair after starting cancer treatment with gefitinib.

Low-dose radiation therapy may improve brain function in some Alzheimer's patients and is generally well-tolerated.

The document concludes that accurately identifying leukemia types is crucial, and the risks of cancer from finasteride need careful evaluation against its benefits.

Finasteride for hair loss may increase the risk of certain cancers and has side effects; better regulation and education on its use are needed.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Docetaxel is effective against various cancers but mainly causes neutropenia.

Adding chemotherapy to tamoxifen improves survival for older breast cancer patients with positive nodes.

Palliative chemotherapy is cost-effective for advanced gastric and colorectal cancer but not clearly for pancreatic-biliary cancer.

Higher doses of cranial irradiation are linked to permanent hair loss.

Cetuximab can cause excessive eyelash growth.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.